Technology News and Research

RSS

Positive results from Pearl Therapeutics' PT005 Phase 2a trial for COPD

Pearl Therapeutics Inc., a company developing high-quality combination therapies for the treatment of highly prevalent chronic respiratory diseases, today announced positive results from its first clinical trial in patients with chronic obstructive pulmonary disease (COPD).

5 Jan 2010

A 'cocktail' to kill cancerous tumors

A team of researchers in California and Massachusetts has developed a "cocktail" of different nanometer-sized particles that work in concert within the bloodstream to locate, adhere to and kill cancerous tumors.

5 Jan 2010

EPO approves Advaxis patent application for Listeria Antigens

Advaxis, Inc., the live, attenuated Listeria monocytogenes (Lm) immunotherapy company, has received notification from the European Patent Office (EPO) that Advaxis patent application 98957980.0 titled “Bacterial Vaccines Comprising Auxotrophic, Attenuated Strains of Listeria Expressing Heterologous Antigens,” has been granted and will be issued as patent #1032417

4 Jan 2010

U.S. encounter with swine flu highlights health system weaknesses

As the number of H1N1 (swine flu) cases in the U.S. continues to wane, the New York Times reflects on how federal officials handled the pandemic and other factors that helped the situation. "The outbreak highlighted many national weaknesses: old, slow vaccine technology; too much reliance on foreign vaccine factories; some major hospitals pushed to their limits by a relatively mild epidemic," the newspaper writes.

4 Jan 2010

Tactx Medical acquired by Creganna

Creganna, a leading supplier of technologies and services to medical device and lifesciences companies today announced that it has acquired Avalon Medical Services Pte Ltd. which trades as Tactx Medical Inc.

4 Jan 2010

Bausch & Lomb launches Crystalens AO intraocular lens

Bausch & Lomb today announced that it is launching the Crystalens® AO, the first aberration-free accommodating intraocular lens (IOL) with aspheric optics to cataract surgeons worldwide.

4 Jan 2010

Sunlighten to unveil mPulse Series in April 2010

Sunlighten(TM) (www.sunlighten.com) is proud to unveil its mPulse(TM) Series, set to launch in April 2010, which is the world's first sauna with personalized biofeedback tracking as well as customizable full spectrum infrared heat that targets specific health concerns.

4 Jan 2010

Dicerna Pharmaceuticals and Kyowa Hakko Kirin sign research collaboration and license agreement

Dicerna Pharmaceuticals, Inc., (Dicerna) a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and Dicer Substrate siRNA (DsiRNA) molecules, and Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), one of Japan's leading biopharmaceutical companies, announced today that the two companies have entered into a research collaboration and license agreement for the research, development and commercialization of drug delivery systems and DsiRNA pharmaceuticals for therapeutic targets in oncology.

4 Jan 2010

Continua Health Alliance to showcase new end-to-end connected health solution at 2010 Consumer Electronics Show

Continua Health Alliance today announced the first end-to-end connected health solution based on the Continua architecture. Continua, the non-profit, open industry alliance of more than 220 leading healthcare and technology organizations, heralded the development as a significant milestone in the group’s mission to establish an ecosystem of interoperable personal connected health solutions.

4 Jan 2010

Revance Therapeutics closes $35 million Series D financing

Revance Therapeutics, Inc. (“Revance”) today announced the first $25 million closing of a $35 million Series D financing. The round was led by Essex Woodlands Health Ventures Fund VIII.

4 Jan 2010

Carbon nanotube: A viable alternative for rapid DNA sequencing

Faster sequencing of DNA holds enormous potential for biology and medicine, particularly for personalized diagnosis and customized treatment based on each individual's genomic makeup.

4 Jan 2010

WDI utilizes DXA analysis for fitness and weight management programs

Women's Digital Imaging of Ridgewood (WDI), has begun using Dual Energy X-ray Absorptiometry (DXA), a technology developed to screen for osteoporosis (bone loss), to measure body fat in patients who want a more accurate method of establishing goals and measuring results for weight management and fitness programs.

4 Jan 2010

EGS receives U.S. patent covering its SerosaFuse fastener and “over the wire” delivery system

EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that the U.S. Patent and Trademark Office has issued a key patent covering its SerosaFuse fastener and “over the wire” delivery system.

4 Jan 2010

Simulated Environment Concepts completes negotiations with Zen & O to manufacture 250 SpaCapsules

Simulated Environment Concepts, Inc., makers of the high pressurized dry water massage and relaxation station SpaCapsule, announced that it has completed negotiations with the French company Zen & O, securing a multi-million dollar deal to manufacture 250 SpaCapsules over the next four years.

4 Jan 2010

Scientists identify genetic marker to diagnose DFTD

An international team of scientists led by a Cold Spring Harbor Laboratory (CSHL) investigator has discovered that the deadly facial tumors decimating Australia's Tasmanian devil population probably originated in Schwann cells, a type of tissue that cushions and protects nerve fibers.

4 Jan 2010

International Isotopes submits a license application for its uranium de-conversion and fluorine extraction project

International Isotopes Inc. announces it has submitted its license application to the U. S. Nuclear Regulatory Commission (NRC) for its depleted uranium de-conversion and fluorine extraction processing facility.

3 Jan 2010

Anika Therapeutics acquires Fidia Farmaceutici subsidiary FAB

Anika Therapeutics, Inc. today announced that it has acquired Fidia Advanced Biopolymers, s.r.l. (“FAB”), a wholly-owned subsidiary of privately held Italian pharmaceutical company, Fidia Farmaceutici S.p.A. FAB provides hyaluronic acid-based (“HA”) products in several therapeutic areas including for the regeneration of connective and structural tissues damaged by injuries, aging or degenerative diseases.

3 Jan 2010

Acacia Research's subsidiary enters into license agreement with Stryker

Acacia Research Corporation announced today that its Hospital Systems Corporation subsidiary has entered into a license agreement with Stryker Corporation and Stryker Imaging Corporation covering a portfolio of patents that relate to medical picture archiving and communication system (PACS) technology.

From Stryker 31 Dec 2009

CMS and ONC issue regulations to implement widespread adoption of EHR incentive programs

The U.S. Department of Health and Human Services’ Centers for Medicare & Medicare Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC) encourage public comment on two regulations issued today that lay a foundation for improving quality, efficiency and safety through meaningful use of certified electronic health record (EHR) technology.

31 Dec 2009

Go beyond ordinary with new arrivals from Spring 2010 Scrubs & Beyond catalog

Go beyond ordinary with new arrivals from the Spring 2010 Scrubs & Beyond catalog! The latest catalog begins arriving the week of January 5th, but new spring merchandise is online now at Scrubs & Beyond.

31 Dec 2009